• SMYD2 Inhibition Attenuates Cisplatin-Induced Renal Fibrosis

  2026-05-06

  This study demonstrates that pharmacological inhibition of SMYD2, using agents such as LLY-507, significantly mitigates renal fibrosis and inflammation in a cisplatin-induced chronic kidney disease model. These findings highlight SMYD2 as a promising epigenetic target for fibrosis intervention and suggest mechanistic links to Smad3/STAT3 pathways.

• Trifluoperazine 2HCl: Applied Workflows for Dopamine D2 Inhi

  2026-05-05

  Trifluoperazine 2HCl stands out as a high-affinity dopamine D2 receptor inhibitor, enabling precise modulation of dopaminergic signaling in both neuropharmacology and immuno-oncology research. This article delivers actionable protocols, workflow enhancements, and troubleshooting strategies—maximizing experiment reproducibility and cross-domain insights.

• PLGA Nanoadjuvant Enhances Mucosal Immunity in Chick H9N2 Va

  2026-05-05

  This study introduces a PLGA-based nano-adjuvant (PEI-LSP-RA-PLGA) that substantially improves both mucosal and systemic immunity in chicks vaccinated against H9N2 avian influenza. The work demonstrates the importance of intestinal targeting and sustained antigen release for effective IgA-mediated defense, with implications for next-generation vaccine design.

• EPZ-6438 in Translational Epigenetic Cancer Research: Mechan

  2026-05-04

  Explore the advanced mechanistic role of EPZ-6438 as a potent EZH2 inhibitor in epigenetic cancer research. This in-depth analysis reveals how recent breakthroughs and practical assay guidance elevate experimental design beyond standard workflows.

• Flumequine: Potent DNA Topoisomerase II Inhibitor for Resear

  2026-05-04

  Flumequine is a chemically defined, small-molecule DNA topoisomerase II inhibitor widely used in DNA replication research. Its high purity, specificity, and consistent IC50 value make it a benchmark tool for in vitro studies involving DNA damage and repair. This article details its validated applications, protocol parameters, and limitations.

• C. difficile Responses to Human Mucus: Insights from IEC Co-

  2026-05-03

  This study introduces a novel primary human intestinal epithelial cell (IEC) co-culture system that models physiologic mucus and enables detailed analysis of Clostridioides difficile's transcriptomic, metabolic, and behavioral adaptations to the mucus barrier. The findings reveal that IEC-derived mucus promotes C. difficile growth and induces distinct metabolic shifts and biofilm formation, offering a refined understanding of pathogenesis in the absence of microbiota.

• Metformin HCl Inhibits Achilles Tendon Ossification via Nr4a

  2026-05-02

  This study elucidates how Metformin Hydrochloride suppresses heterotopic ossification in mouse Achilles tendon by downregulating the Nr4a1/Wnt/β-catenin signaling axis. The findings reveal a novel non-metabolic mechanism for metformin, highlighting its potential in bone biology and pathological ossification research.

• Q-VD-OPh: Advanced Pan-Caspase Inhibition in Apoptosis Resea

  2026-05-01

  Q-VD-OPh sets the benchmark for selective, irreversible pan-caspase inhibition across diverse experimental models, enabling precise dissection of apoptotic pathways. This guide spotlights practical workflows, troubleshooting strategies, and translational use-cases—backed by recent mechanistic insights and protocol-level data.

• Thiamet G: Applied O-GlcNAcase Inhibition for Advanced Assay

  2026-05-01

  Thiamet G, a potent O-GlcNAcase inhibitor from APExBIO, enables precise modulation of O-GlcNAcylation for translational research in neurodegeneration, oncology, and placental disease. This guide delivers actionable protocols, troubleshooting, and experimental insights that maximize data quality across diverse cell and animal models.

• 2,2,2-Trichloroethanol: Precision in Dopaminergic Neuron & P

  2026-04-30

  Explore the unique role of 2,2,2-Trichloroethanol as a small molecule biochemical for advanced molecular biology and dopaminergic neuron research. This article offers a deeper look at assay decision-making, bridging protein and neurobiology workflows.

• Sildenafil Citrate: Protocols and Pitfalls in cGMP Signaling

  2026-04-30

  Leverage Sildenafil Citrate’s high selectivity as a cGMP-specific phosphodiesterase type 5 inhibitor to dissect vascular smooth muscle relaxation, apoptosis regulation, and proteoform-specific signaling. This guide details optimized experimental workflows, troubleshooting strategies, and actionable insights from cutting-edge proteomics studies, ensuring robust, reproducible results for advanced vascular and cellular research.

• PLK1-Dependent Control of p31comet in Mitotic Checkpoint Dis

  2026-04-29

  This study elucidates how Polo-like kinase 1 (PLK1) regulates the mitotic checkpoint component p31comet by direct phosphorylation, thereby modulating the disassembly of mitotic checkpoint complexes (MCC) and ensuring accurate chromosome segregation. The findings reveal a negative regulatory mechanism by which PLK1 prevents premature MCC disassembly, offering key insights for cell cycle and cancer biology research.

• Flumequine: Applied Strategies for DNA Topoisomerase II Inhi

  2026-04-29

  Flumequine (APExBIO, B2292) stands out as a high-purity DNA topoisomerase II inhibitor, enabling precise modulation of DNA replication and repair pathways. This guide details actionable workflows, troubleshooting, and comparative advances for researchers seeking robust results in cancer, antibiotic resistance, and DNA damage studies.

• Neomycin Sulfate: Precision in RNA/DNA & Ion Channel Researc

  2026-04-28

  Neomycin sulfate is more than a classic aminoglycoside antibiotic—it's a versatile tool for dissecting RNA/DNA structural interactions and modulating ryanodine receptor channels. Here, discover experimental workflows, troubleshooting insights, and practical benchmarks that set APExBIO’s Neomycin sulfate apart in advanced molecular assays.

• Zolmitriptan as a Research Tool: Beyond Migraine Models

  2026-04-28

  Explore Zolmitriptan’s role as a 5-HT1B receptor agonist in migraine research, with a focus on receptor selectivity, lysosomal crosstalk, and advanced assay design. Discover unique solubility and handling strategies for reliable, high-purity experimentation.

15588 records 1/1040 page Next 12345 下5页 Last page